S49076

• Description:

  S49076 is a novel, potent inhibitor of MET, AXL/MER, and FGFR1/2/3 with IC50 values below 20 nM.

• UNSPSC:

  12352005

• Hazard Statement:

  H302

• Target:

  C-Met/HGFR; FGFR

• Type:

  Reference compound

• Related Pathways:

  Protein Tyrosine Kinase/RTK

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/S49076.html

• Concentration:

  10mM

• Purity:

  99.44

• Solubility:

  DMSO : ≥ 31 mg/mL

• Smiles:

  O=C(N1CC2=CC3=C(NC(/C3=C\C4=CC(CN5CCOCC5)=CN4)=O)C=C2)SCC1=O

• Molecular Formula:

  C22H22N4O4S

• Molecular Weight:

  438.50

• Precautions:

  H302

• References & Citations:

  [1]Burbridge MF, et al. S49076 is a novel kinase inhibitor of MET, AXL, and FGFR with strong preclinical activity alone and in association with bevacizumab. Mol Cancer Ther. 2013 Sep;12 (9) :1749-62.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [1265965-22-7]